Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
The long awaited CRTC review into wireless services kicks off this week with virtually every key stakeholder – the big carriers, regional carriers, independent...
The past year has been an incredibly active one for Canadian digital law and policy with important Supreme Court cases, legislative proposals, committee reports,...
Digital tax policy has emerged as major issue around the world. Canada is no exception. Late last year, the Canadian government announced plans to...